Accessibility Statement

Immunology

Our mission is to make life better for millions of people around the world living with debilitating autoimmune diseases.

Redefining what’s possible means raising the bar for treatments through continued research and innovation. At Lilly, we are developing novel treatment options to help more people achieve better outcomes and reduce the burden of their disease.

With a worldwide team and strong investments in the fields of dermatology, gastroenterology and rheumatology, we are setting new expectations and delivering innovative treatment solutions for people living with autoimmune diseases.

People's everyday experiences living with diseases like atopic dermatitis, alopecia areata, psoriasis, rheumatoid arthritis, Crohn’s disease and ulcerative colitis inspire us to go further to help make lives better.

Together we embrace the challenge to redefine what's possible.

woman of color scratching neck

Innovative Atopic Dermatitis Skin of Color Clinical Trial

Learn More About the Trial

Living With Ankylosing Spondylitis

Meet Caroline: a busy mom, keeping up with her kids and juggling schedules. But Caroline lives with an autoimmune disease. Watch her full story on how she lives with ankylosing spondylitis (AS).

Dr. Lotus Mallbris Says 'Yes' to a New Era in Dermatology

Dr. Lotus Mallbris, Lilly’s vice president of immunology development says "yes" to many things – including a transition from doctor to researcher, her devotion to patient care and Lilly’s commitment to discovery in a new era of dermatology.

Immunology is one of five core disease areas at Lilly, along with diabetes, cancer, pain and neurodegeneration.